From Nutraceuticals World
Expanding its product portfolio, Nutrition 21, Inc., Purchase, NY, has received an exclusive license in the U.S. from Denmark-based Provita Development ApS for Coldizin, an ingredient combination patented in the U.S. and Europe for enhancing upper-respiratory health. A patent is pending in Canada. The exclusive license allows Nutrition 21 to expand its product portfolio with a novel, clinically substantiated ingredient for the $4.5 billion U.S. cough and cold category.
Read More
Strategy. Communications. Trade Relations.
Wednesday, December 1, 2010
Monday, November 15, 2010
NDIs, Adulteration on AHPA’s Radar
From Natural Products INSIDER
While notification to FDA of new dietary ingredients (NDIs) has been a requirement since the passage of the Dietary Supplement Health & Education Act (DSHEA), many companies continue to struggle to understand the process. Virgo Publishing’s Jon Benninger spoke with Michael McGuffin, president of the American Herbal Products Association (AHPA), during SupplySide West in October 2010 regarding NDIs and other hot industry issues, after McGuffin spoke on a panel about NDIs.
Read More
While notification to FDA of new dietary ingredients (NDIs) has been a requirement since the passage of the Dietary Supplement Health & Education Act (DSHEA), many companies continue to struggle to understand the process. Virgo Publishing’s Jon Benninger spoke with Michael McGuffin, president of the American Herbal Products Association (AHPA), during SupplySide West in October 2010 regarding NDIs and other hot industry issues, after McGuffin spoke on a panel about NDIs.
Read More
Tuesday, November 9, 2010
Nutrition 21 Awarded Grant for Diabetic Technology
From Natural Products INSIDER
Nutrition 21 Inc., the developer and marketer of clinically substantiated ingredients for dietary supplements, foods and beverages, and animal nutrition, announced the award of a cash grant of up to $104,350 from the Federal Qualifying Therapeutic Discovery Project (QTDP) Program to help further develop its patent pending chromium-enhanced insulin technology for use in the treatment of type 1 and type 2 diabetes.
Read More
Nutrition 21 Inc., the developer and marketer of clinically substantiated ingredients for dietary supplements, foods and beverages, and animal nutrition, announced the award of a cash grant of up to $104,350 from the Federal Qualifying Therapeutic Discovery Project (QTDP) Program to help further develop its patent pending chromium-enhanced insulin technology for use in the treatment of type 1 and type 2 diabetes.
Read More
Wednesday, November 3, 2010
Election Brings Potential Threats to Natural Product Industry
From Natural Products INSIDER
John Gay from the Natural Products Association (NPA) called yesterday’s mid-terms “the most remarkable election in my 25 years in Washington," and the natural product industry advocacy group said it will stay abreast of potential threats from the “lame duck" session still in power and the potential changes that will come with new government officials.
Read More
John Gay from the Natural Products Association (NPA) called yesterday’s mid-terms “the most remarkable election in my 25 years in Washington," and the natural product industry advocacy group said it will stay abreast of potential threats from the “lame duck" session still in power and the potential changes that will come with new government officials.
Read More
Monday, November 1, 2010
Supplement Usage Remains Steady
From Nutraceuticals World
A consistent percentage of U.S. adults label themselves as supplement users, with 66% classifying themselves as such, according to a survey conducted by Ipsos-Public Affairs for the Council for Responsible Nutrition (CRN), Washington, D.C. In 2009, 65% identified themselves as supplement users compared with 64% in 2008, 68% in 2007 and 66% in 2006.
According to results from the 2010 CRN Consumer Survey on Dietary Supplements, regular supplement usage also remains steady. The online survey showed that nearly three-quarters of supplement users (74%) classify themselves as “regular” users, as opposed to occasional users (21%) or seasonal users (5%). In 2009, 73% of supplement users indicated they took supplements regularly; in 2008, 75%, and in 2007, 77% indicated similarly.
Read More
A consistent percentage of U.S. adults label themselves as supplement users, with 66% classifying themselves as such, according to a survey conducted by Ipsos-Public Affairs for the Council for Responsible Nutrition (CRN), Washington, D.C. In 2009, 65% identified themselves as supplement users compared with 64% in 2008, 68% in 2007 and 66% in 2006.
According to results from the 2010 CRN Consumer Survey on Dietary Supplements, regular supplement usage also remains steady. The online survey showed that nearly three-quarters of supplement users (74%) classify themselves as “regular” users, as opposed to occasional users (21%) or seasonal users (5%). In 2009, 73% of supplement users indicated they took supplements regularly; in 2008, 75%, and in 2007, 77% indicated similarly.
Read More
Wednesday, October 20, 2010
Robinson Pharma Hires R and D, Quality Ops Staff
From Natural Products INSIDER
Robinson Pharma Inc. (RPI) hired Emad Hassan, Ph.D., Hassen Nasri, Ph.D., and expanded its sales team. Emad Hassan obtained his undergraduate in pharmaceutical science with honors from the University of Alexandria, Egypt and completed his Ph.D. in pharmaceutics at the University of Georgia College of Pharmacy. An expert in drug delivery systems with experience in oral, parenteral, topical, transdermal, liquids, liquid encapsulation and nanotechnology, his record of achievement includes eight issued patents, more than 50 publications and presentations, and more than 200 pharmaceutical products now in the market.
Read More
Robinson Pharma Inc. (RPI) hired Emad Hassan, Ph.D., Hassen Nasri, Ph.D., and expanded its sales team. Emad Hassan obtained his undergraduate in pharmaceutical science with honors from the University of Alexandria, Egypt and completed his Ph.D. in pharmaceutics at the University of Georgia College of Pharmacy. An expert in drug delivery systems with experience in oral, parenteral, topical, transdermal, liquids, liquid encapsulation and nanotechnology, his record of achievement includes eight issued patents, more than 50 publications and presentations, and more than 200 pharmaceutical products now in the market.
Read More
WILD Flavors, Sterling Technology Form Partnership
From Nutraceuticals World
Adding to its Health Ingredient Technology & Solutions (H.I.T.S.) lineup, WILD Flavors, Erlanger, KY, has established a partnership with Sterling Technology, Brookings, SD, making WILD the exclusive provider of Immunel and Tegricel bioactive milk peptide products. The new partnership will combine Sterling's scientific research expertise in bioactive milk peptides with WILD’s product development and flavor expertise.
Adding to its Health Ingredient Technology & Solutions (H.I.T.S.) lineup, WILD Flavors, Erlanger, KY, has established a partnership with Sterling Technology, Brookings, SD, making WILD the exclusive provider of Immunel and Tegricel bioactive milk peptide products. The new partnership will combine Sterling's scientific research expertise in bioactive milk peptides with WILD’s product development and flavor expertise.
Subscribe to:
Posts (Atom)
